Literature DB >> 6687559

Differences in the sensitivities of murine metastatic lymphoma/lymphosarcoma variants to macrophage-mediated cytolysis and/or cytostasis.

K M Miner, G L Nicolson.   

Abstract

A metastasizing animal tumor model for large cell lymphoma or lymphosarcoma has been established by sequential selection in vivo of the RAW117 parental cell line in BALB/c mice for enhanced colonization of liver or lung and in vitro for lack of binding to immobilized lectins. The parental RAW117 and selected sublines and clones derived from these were compared for their sensitivities in vitro to polyinosinic:polycytidylic acid-activated syngeneic macrophages in cytolysis and cytostasis assays. Activated but not unactivated macrophages had differing effects on RAW117 sublines and clones. The least metastatic (parental) cell line was the most sensitive to activated macrophage-mediated cytolysis and cytostasis, while the most metastatic subline was the least sensitive in these assays. Intermediate metastatic sublines or cones were usually less sensitive in one or both of the assays. These antitumor activities were negligible at 24 hr in the continuous presence of polyinosinic:polycytidylic acid but were clearly apparent by 48 to 72 hr. The results suggest that differential sensitivity to host macrophage surveillance mechanisms can occur in malignant cell subpopulations.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6687559

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Development of lymphosarcoma lines with high metastatic ability to lymph nodes and visceral organs in BALB/c mice.

Authors:  T Tsuruo; T Oh-Hara; T Yamori; S Tsukagoshi; T Ishikawa; H Sugano
Journal:  Clin Exp Metastasis       Date:  1988 Mar-Apr       Impact factor: 5.150

2.  Cancer chemotherapeutics as immunomodulators.

Authors:  F Spreafico; A Vecchi; F Colotta; A Montovani
Journal:  Springer Semin Immunopathol       Date:  1985

3.  Tumor progression, oncogenes and the evolution of metastatic phenotypic diversity.

Authors:  G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1984 Apr-Jun       Impact factor: 5.150

4.  Expression of abl and other oncogenes is independent of metastatic potential in Abelson virus-transformed malignant murine large cell lymphoma.

Authors:  V Rotter; D Wolf; M Blick; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1985 Apr-Jun       Impact factor: 5.150

5.  Interaction of high or low metastatic related tumor lines with normal or lymphokine-activated syngeneic peritoneal macrophages: in vitro analysis of tumor cell binding and cytostasis.

Authors:  V Schirrmacher; B Appelhans
Journal:  Clin Exp Metastasis       Date:  1985 Jan-Mar       Impact factor: 5.150

Review 6.  Generation of phenotypic diversity and progression in metastatic tumor cells.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

7.  Preventing diversification of malignant tumor cells during therapy.

Authors:  G L Nicolson; R Lotan
Journal:  Clin Exp Metastasis       Date:  1986 Oct-Dec       Impact factor: 5.150

8.  Differential organ tissue adhesion, invasion, and growth properties of metastatic rat mammary adenocarcinoma cells.

Authors:  G L Nicolson
Journal:  Breast Cancer Res Treat       Date:  1988-10       Impact factor: 4.872

9.  Selection for enhanced adhesion to microvessel endothelial cells or resistance to interferon-gamma modulates the metastatic potential of murine RAW117 large-cell lymphoma cells.

Authors:  R A LaBiche; R J Tressler; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1993-11       Impact factor: 5.150

Review 10.  Adhesion molecules and their role in cancer metastasis.

Authors:  R M Lafrenie; M R Buchanan; F W Orr
Journal:  Cell Biophys       Date:  1993 Aug-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.